why is retatrutide better than semaglutide vs Mounjaro vs Ozempic: 2026 Data Decisive Semaglutide vs Tirzepatide vs Retatrutide:

Look at both the monthly payment and total cost over time, not just the lowest monthly number

Further population-based studies may quantify incidence rates, characterize dose-dependent relationships, and investigate mechanistic pathways to optimize risk stratification and therapeutic decision-making

CNN Healths Meg Tirrell contributed to this story.

Semaglutide (as Ozempic) has more extensive data in diabetic populations and proven cardiovascular benefits

Resistance training and high protein intake of 1.2-1.6 g/kg/day recommended to minimize muscle loss, PMID: 40609566) Mild-to-moderate cardiac arrhythmias reported in some participants long-term cardiovascular outcome data pending from the 113-week TRIUMPH-3 trial (PMID: 37902090) Dose-dependent GI side effect profile adverse event rates roughly doubled between 1 mg and 8 mg groups in Phase 2, making gradual titration critical Phase 2 discontinuation rate for adverse events: 5-10% at highest doses comparable to discontinuation rates seen with semaglutide and tirzepatide Potential blood glucose effects in non-diabetic individuals due to glucagon receptor activation the glucagon component raises and the GLP-1/GIP components lower blood glucose, creating complex interactions under investigation in Phase 3 Long-term safety data beyond 68 weeks not yet available the 113-week TRIUMPH-3 trial in cardiovascular disease patients will provide the longest safety dataset when results are reported Dosing protocol Typical Dose 1 mg to 12 mg weekly (Phase 2/3 doses) Frequency Once weekly subcutaneous injection Not yet FDA-approved all dosing information reflects clinical trial protocols, not prescribing guidance

Compounded semaglutide and tirzepatide from licensed 503A pharmacies meet USP standards and state pharmacy regulations